Skip to main
OHI

OHI Stock Forecast & Price Target

OHI Analyst Ratings

Based on 11 analyst ratings
Hold
Strong Buy 18%
Buy 18%
Hold 55%
Sell 9%
Strong Sell 0%

Bulls say

Omega Healthcare Invts is well-positioned to take advantage of growth opportunities in the healthcare real estate market, as the company primarily invests in high-demand properties such as skilled nursing facilities and seniors housing communities. In addition, positive trends in the healthcare industry, such as an aging population and rising demand for healthcare services, bode well for the company's future performance and ability to provide attractive returns to investors. Finally, Omega's diverse portfolio, spread across multiple geographic regions and leased to a wide range of operator partners, provides stability and reduces risks for the company.

Bears say

Omega Healthcare Invts is a real estate investment trust that invests in healthcare-related properties in the U.S., U.K., and Canada. Despite strong earnings and a high price target, the company is facing potential Medicaid cuts, tenant issues, and a challenging SNF environment, which may lower its AFFO estimate and lead to a decline in stock price. Additionally, the ongoing Genesis bankruptcy process and portfolio repositioning may also impact the company's performance and ability to deploy capital, further adding to the downside risk. As such, our outlook remains negative on the stock.

OHI has been analyzed by 11 analysts, with a consensus rating of Hold. 18% of analysts recommend a Strong Buy, 18% recommend Buy, 55% suggest Holding, 9% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Omega Healthcare Investors and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Omega Healthcare Investors (OHI) Forecast

Analysts have given OHI a Hold based on their latest research and market trends.

According to 11 analysts, OHI has a Hold consensus rating as of Jun 27, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $48.09, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $48.09, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Omega Healthcare Investors (OHI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.